why is the fda banning bpc 157 BPC-157: Real Reason It's Not Approved BPC 157 Banned: Key Facts

Similar patterns have been found in oral cancer and in patients receiving immunotherapy, where elevated B12 has been associated with poorer outcomes

Yes, we supply our BPC-157 10 mg (10 Vials) exclusively for laboratory research purposes

These include: Neurological symptoms : tingling or numbness in hands and feet (paraesthesia), difficulty walking, balance problems, memory difficulties, or mood changes Haematological signs : ongoing fatigue, weakness, pale skin, or shortness of breath suggesting anaemia hasn't resolved Glossitis : a sore, red tongue that hasn't improved Cognitive issues : continued difficulty concentrating or memory problems These symptoms, particularly progressive neurological deficits or severe anaemia with cardiorespiratory compromise, may require urgent medical attention

Cochrane review)